Founded in 2016, Beijing Darwin Biotech is a biopharmaceutical enterprise dedicated to developing therapies for central nervous system (CNS) diseases. The company focuses on developing stem cell and stem cell-derived technologies, aiming to address the global medical challenge of neural repair. Leveraging proprietary technologies, we have successfully isolated and screened stem cell-derived components with exceptional neurorestorative activity. Our breakthroughs in treating neurological injuries (e.g., stroke-induced damage) and neurodegenerative diseases have garnered significant attention in the biopharmaceutical community.
Address
BeijingBeijing
China
